Annual report pursuant to Section 13 and 15(d)

RELATED PARTY TRANSACTIONS

v3.22.0.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS
 
Our joint venture in China, owned 80 percent by us and 20 percent by a wholly owned subsidiary of Fosun Pharma, borrowed $0 from the Company during the years ended December 31, 2021 and 2020. At December 31, 2021 and 2020 our joint venture in China held a note payable to the Company of $1.2 million and $4.8 million, respectively. Our joint venture in China borrowed $0 from our joint venture partner, during the years ended December 31, 2021 and 2020. At December 31, 2021 and 2020, our joint venture in China held a note payable to our joint venture partner of $0.3 million and $1.2 million,
respectively. These notes are payable in one year and bear interest of 3.0 percent. The note between the joint venture and the Company eliminates in consolidation.